Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Autoimmunity

Does autoantigen complementarity underlie PR3-ANCA AAV?

New data unexpectedly suggest that sera from patients with PR3-ANCA-associated vasculitis are less reactive than those of healthy controls to the 'antisense' product of the PR3 gene. How does this result fit with the theory of autoantigen complementarity, and the proposed role of anti-idiotypic antibodies in the development of ANCA-associated vasculitis?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Recovery of masked antibody idiotypes by specific blocking of anti-idiotypic antibodies.

References

  1. Tadema, H., Kallenberg, C. G., Stegeman, C. A. & Heeringa, P. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA -associated vasculitis. PLoS ONE 6, e17972 (2011).

  2. Mekler, L. B. Specific selective interaction between amino acid groups of polypeptide chains [Russian]. Biofizika 14, 581–584 (1969).

    CAS  PubMed  Google Scholar 

  3. Blalock, J. E. Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA. Trends Biotechnol. 8, 140–144 (1990).

    Article  CAS  Google Scholar 

  4. Pendergraft, W. F. III. et al. Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3. Nat. Med. 10, 72–79 (2004).

    Article  CAS  Google Scholar 

  5. Cao, Y. et al. DRB1*15 allele is a risk factor for PR-3 ANCA disease in African Americans. J. Am. Soc. Nephrol. (in press).

  6. Hewins, P., Belmonte, F., Charles Jennette, J., Falk, R. J. & Preston, G. A. Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N. Autoimmunity 44, 98–106 (2011).

    Article  CAS  Google Scholar 

  7. Bautz, D. J. et al. Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J. Am. Soc. Nephrol. 19, 2421–2429 (2008).

    Article  CAS  Google Scholar 

  8. Oak, S., Radtke, J., Törn, C., Landin-Olsson, M. & Hampe, C. S. Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals. Scand. J. Immunol. doi:10.1111/j.1365–30832011.02565.x.

  9. Routsias, J. G. et al. Unmasking the anti-La/SSB response in sera from patients with Sjögren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol. Med. 8, 293–305 (2002).

    Article  CAS  Google Scholar 

  10. Tzioufas, A. G. & Routsias, J. G. Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application. Autoimmun. Rev. 9, 631–633 (2010).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors' research activities are supported by Grant 2PO1DK from the National Institute of Diabetes and Digestive and Kidney Diseases/NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald Falk.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preston, G., Falk, R. Does autoantigen complementarity underlie PR3-ANCA AAV?. Nat Rev Rheumatol 7, 439–440 (2011). https://doi.org/10.1038/nrrheum.2011.86

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2011.86

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing